The Variant at TGFBRAP1 but Not TGFBR2 Is Associated with Antituberculosis Drug-Induced Liver Injury.

Jingwei ZhangZhenzhen ZhaoHao BaiLin JiaoQian WuTao WuTangyuheng LiuXuejiao HuJiajia SongMengyuan LyvBinwu Ying

Published in: Evidence-based complementary and alternative medicine : eCAM (2019)

Our study first implied that the A variant of rs17687727 in TGFBRAP1 influenced the susceptibility to ATDILI in first-line antituberculosis combination treatment in the Han Chinese population in a dependent manner.

Keyphrases

emergency department
combination therapy
adverse drug
drug induced
replacement therapy
smoking cessation